Chesterton Lindsay J, Priestman William S, Lambie Stewart H, Fielding Catherine A, Taal Maarten W, Fluck Richard J, McIntyre Christopher W
Department of Renal Medicine, Derby City General Hospital, Derby, UK.
Hemodial Int. 2006 Oct;10(4):346-50. doi: 10.1111/j.1542-4758.2006.00127.x.
Considerable intrinsic intrapatient variability influences the actual delivery of Kt/V. The aim of this study is to examine the feasibility of using continuous online assessment of ionic dialysance measurements (Kt/V(ID)) to allow dialysis sessions to be altered on an individual basis. Ten well-established chronic hemodialysis (HD) patients without significant residual renal function were studied (mean age 65+/-4.3 [38-81] years, mean length of time on dialysis 66+/-18 [14-189] months). These patients had all been receiving thrice-weekly 4-hr dialysis using Integra dialysis monitors. Dialysis monitors were equipped with Diascan modules permitting measurement of Kt/V(ID). Predicted treatment time required to achieve a Kt/V(ID) > or = 1.1 (equivalent to a urea-based method of 1.2) was calculated from the delivered Kt/V(ID) at 60 and 120 min. Treatment time was reprogrammed at 2 hr (ensuring all planned ultrafiltration would be accommodated into the new modified session duration). Owing to practical issues, and to avoid excessively short dialysis times, these changes were censored at no more than+/-10% of the usual 240-min treatment time (210-265 min). Data were collected from a total of 50 dialysis sessions. Almost all sessions (47/50) required modification of the standard treatment time: 13/50 sessions were lengthened and 34/50 shortened (mean length of session 232.2+/-2.5 [210-265] min). A Kt/V(ID) of > or = 1.1 was achieved in 39/50 sessions. The difference in mean urea-based Kt/V poststudy (1.3+/-0.05 [1.1-1.6]) and mean achieved Kt/V(ID) (1.16+/-0.02 [0.7-1.37]) was significant (p = 0.002). The use of individualized variable dialysis treatment time using online ionic dialysance measurements of Kt/V(ID) appears both practicable and effective at ensuring consistently delivered adequate dialysis.
患者体内存在显著的内在变异性,这会影响Kt/V的实际输送量。本研究的目的是探讨利用离子透析率测量值(Kt/V(ID))的连续在线评估来允许根据个体情况调整透析疗程的可行性。对10名已确诊的慢性血液透析(HD)患者进行了研究,这些患者没有显著的残余肾功能(平均年龄65±4.3[38 - 81]岁,平均透析时间66±18[14 - 189]个月)。这些患者均使用Integra透析监测仪每周进行三次4小时的透析。透析监测仪配备了Diascan模块,可测量Kt/V(ID)。根据60分钟和120分钟时输送的Kt/V(ID)计算达到Kt/V(ID)≥1.1(相当于基于尿素的方法为1.2)所需的预测治疗时间。在2小时时重新设定治疗时间(确保所有计划的超滤量都能纳入新的调整后的疗程时长)。由于实际问题,并为避免透析时间过短,这些变化被限制在通常240分钟治疗时间的±10%以内(210 - 265分钟)。共收集了50次透析疗程的数据。几乎所有疗程(47/50)都需要调整标准治疗时间:13/50次疗程延长,34/50次疗程缩短(平均疗程时长232.2±2.5[210 - 265]分钟)。50次疗程中有39次达到了Kt/V(ID)≥1.1。研究后基于尿素的平均Kt/V(1.3±0.05[1.1 - 1.6])与平均达到的Kt/V(ID)(1.16±0.02[0.7 - 1.37])之间的差异具有统计学意义(p = 0.002)。利用Kt/V(ID)的在线离子透析测量进行个体化可变透析治疗时间的方法,在确保始终提供充分透析方面似乎既可行又有效。